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ABSTRACT The infectious agent of transmissible spon-
giform encephalopathies is believed to consist of an oligomeric
isoform, PrPSc, of the monomeric cellular prion protein, PrPC.
The conversion of PrPC to PrPSc is characterized by a decrease
in a-helical structure, an increase in b-sheet content, and the
formation of PrPSc amyloid. Whereas the N-terminal part of
PrPC comprising residues 23–120 is f lexibly disordered, its
C-terminal part, PrP(121–231), forms a globular domain with
three a-helices and a small b-sheet. Because the segment of
residues 90–231 is protease-resistant in PrPSc, it is most likely
structured in the PrPSc form. The conformational change of
the segment containing residues 90–120 thus constitutes the
minimal structural difference between PrPC and a PrPSc
monomer. To test whether PrP(121–231) is also capable to
undergo conformational transitions, we analyzed its urea-
dependent unfolding transitions at neutral and acidic pH. We
identified an equilibrium unfolding intermediate of PrP(121–
231) that is exclusively populated at acidic pH and shows
spectral characteristics of a b-sheet protein. The intermediate
is in rapid equilibrium with native PrP(121–231), significantly
populated in the absence of urea at pH 4.0, and may have
important implications for the presumed formation of PrPSc
during endocytosis.
Prions constitute the infectious agents of fatal neurodegen-
erative illnesses such as the Creutzfeldt–Jakob disease, the
Gerstmann–Sträussler–Scheincker syndrome, fatal familial in-
somnia, and kuru in humans, bovine spongiform encephalop-
athy in cattle, and scrapie in sheep (1–3). According to the
‘‘protein-only’’ hypothesis (4–6), the prion is believed to
consist mostly, if not entirely, of the oligomeric scrapie isoform
prion protein PrPSc, of the host-encoded monomeric cellular
prion protein PrPC. PrPSc is most likely identical in its covalent
structure with PrPC (7). Both forms of the prion protein thus
appear to differ only in their three-dimensional structure, as
Fourier-transform infrared spectra and CD spectra indicate
that the b-sheet content of PrPSc is significantly increased
compared with PrPC (8, 9).
Two different kinetic models for the self-replication of PrPSc
have been proposed. In the first model, the rate-limiting step
would be the irreversible autocatalytic conversion of mono-
meric PrPC to a monomeric PrPSc subunit, followed by fast
oligomerization of the subunits (10). This model has, however,
been questioned recently by simulations of the kinetics of prion
formation (11). In the second model, a fast equilibrium
between monomeric PrPC and a monomeric PrPSc precursor is
proposed and the rate-limiting reaction would be the forma-
tion of a PrPSc oligomer, which acts as nucleus for the growth
of larger oligomers of the infectious agent (12).
PrPC is a secretory cell surface glycoprotein. Its mature form
made up of the residues 23–231 [amino acid numbering
according to human PrP (13)] is anchored to the cell mem-
brane via a glycosyl phosphatidylinositol anchor at its C
terminus (7). It has a single disulfide bridge and two N-
glycosylation sites (7). The three-dimensional NMR structure
of the recombinant murine prion protein, PrP(23–231), has
revealed that the whole N-terminal segment 23–120 is f lexibly
disordered and that only the segment containing the C-
terminal 111 residues, PrP(121–231), possesses a defined
three-dimensional structure (14–17). Murine PrP(121–231) is
a self-folding domain consisting of three a-helices and a
two-stranded antiparallel b-sheet (14, 15). The structure of the
isolated domain PrP(121–231) is the same as that in the context
of the murine full-length protein (15, 17). Very similar results
were obtained for the structure of the full-length prion protein,
PrP(29–231), from hamster (18).
Although mature PrPC is soluble and protease-sensitive, the
PrPSc oligomer is insoluble and partially protease-resistant.
Digestion of PrPSc yields a PrP species termed PrP27–30 that
retains infectivity. The frayed N termini of the PrP27–30
subunits are found within residues 73–90 (1). Within the
framework of the “protein-only” hypothesis, the segment
containing residues 90–231 of the prion protein thus appears
to be the minimal infectious unit. This is in accordance with the
finding that transgenic mice that exclusively express an N-
terminally truncated prion protein lacking residues 23–80 are
still susceptible to prion infection and able to propagate the
infectious agent (19). Because segment 90–120 is protected
from protease digestion in PrPSc, it is very likely that residues
90–120 adopt a defined conformation in the PrPSc subunits.
This was confirmed by the identification of PrPC- and PrPSc-
specific epitopes in segment 90–120 with recombinant anti-
body Fab fragments (20). A structural change in segment
90–120 thus appears to be the minimal requirement for the
transition from PrPC to PrPSc.
The aim of this study was to test whether segment 90–120 is
the only region of prion protein that can undergo a structural
change during formation of PrPSc or whether the C-terminal
domain PrP(121–231) is also able to adopt alternative confor-
mations that may be present in PrPSc. For this purpose, we
analyzed the pH dependence of the urea-induced unfolding
transition of murine PrP(121–231) that folds reversibly in a
one-step transition at pH 7.0 (14). Recent experiments on the
folding of the recombinant human and hamster prion protein
fragments 90–231 showed that PrP(90–231) forms an unfold-
ing intermediate at acidic pH with b-sheet character (21, 22).
Herein we show that formation of this intermediate is inde-
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pendent of segment 90–120, fully reversible, and an intrinsic
property of the C-terminal domain PrP(121–231). We present
quantitative data on the population of the intermediate at
acidic pH and discuss its possible implications for the present
models of prion propagation and the presumed formation of
PrPSc during endocytosis.
MATERIALS AND METHODS
Expression and Purification of PrP(121–231). Murine
PrP(121–231) was expressed in the periplasm of Escherichia
coli BL21(DE3) as described (14), except that the bacteria
were grown at 37°C prior to induction and that the expression
vector pPrP-CRR was used. This plasmid differs from the
described plasmid pPrP-C (14) at the codons for Arg-228 and
Arg-229 that were replaced by the most frequent Arg codons
in strongly expressed E. coli genes. The modified gene encod-
ing PrP(121–231) was amplified from pPrP-C by the PCR with
the following oligonucleotide primers: N-terminal primer,
59-GGCTGCGGCAGTCGCGAGTGTAGTGGGGGGCCT-
TGGTGGC-39; C-terminal primer, 59-AGGAGGGGAGGG-
GATCCAAGCTTACTAGCTGGAACGACGCCCGTCGT-
AATAGGCCTGGGACTCC-39.
The amplified gene was cut with NruI and BamHI and
cloned into the plasmid pRBI-PDI-T7 (23) that had been
digested with StuI and BamHI. pPrP-CRR provided about
2-fold higher yields of PrP(121–231) compared with pPrP-C. In
addition, a modified form of PrP(121–231) with an apparent
molecular mass that was about 1 kDa higher on SDSy
polyacrylamide gels and that accumulated to about 10%
compared with PrP(121–231) was no longer observed when
pPrP-CRR was used. N-terminal sequencing and mass spec-
trometry indicated that this modified form had the correct N
terminus but an enlongation at the C-terminus, obviously
caused by the natural codons of Arg-228 and Arg-229 in the
mouse PrP gene, which are the rarest Arg codons in E. coli.
Recombinant PrP(121–231) was purified as described (14),
dialyzed against distilled water, and stored at 220°C. The
concentration of PrP(121–231) was measured by its absor-
bance at 280 nm (A280 nm, 1 mgyml, 1 cm 5 1.55).
CD Spectroscopy. Far-UV CD spectra were measured on a
Jasco J710 CD spectropolarimeter at protein concentrations of
0.3–0.4 mgyml in 0.02-cm cuvettes. Buffers were the same as
those used for measuring the unfoldingyrefolding equilibria
(see below). Spectra were corrected for the buffers.
Unfolding and Refolding of PrP(121–231). Reversible un-
folding and refolding of PrP(121–231) was measured between
pH 4.0 and pH 7.0 at 22°C and a constant ionic strength of 88
mM in the following buffers that contained different concen-
trations of urea: pH 7.0, 50 mM sodium phosphate; pH 6.0, 10
mM MeszNaOHy84 mM NaCl; pH 5.0, 50 mM acetic
acidzNaOHy56 mM NaCl; pH 4.5, 50 mM acetic
acidzNaOHy70 mM NaCl; pH 4.0, 50 mM formic
acidzNaOHy56 mM NaCl. Native or denatured PrP(121–231)
(in 8 M urea) was diluted 1:11 with buffer [final concentration
of PrP(121–231), 22–40 mM] and incubated for 36 h. The mean
residue ellipticity at 222 nm was then recorded for 2 min in
0.1-cm cuvettes and averaged. The original CD data obtained
at pH 7.0, 6.0, and 5.0 were analyzed according to the two-state
model of folding, by using a six-parameter fit as described (24).
Eqs. 1–3 (25) were used for the three-state analysis of the data
measured at pH 4.5 and 4.0, where uN, uI, and uU are the mean
residue ellipticities at 222 nm of the native protein, the
intermediate, and the unfolded protein at 0 M urea; sN and sI
correspond to the slopes of the urea dependence of uN and uU;
DGNI and DGIU are free energy differences between the native
protein and the intermediate and between the intermediate
and the unfolded protein, respectively; and mNI and mIU are
the cooperativities of the transitions.
uobs 5 ~uN1SN [D]) 1 exp a[uI 1 (uU 1 sU[D])exp b]y
[1 1 exp a(1 1 exp b)]. [1]
a 5 ~DGNI 1 mNI[D])yRT. [2]
b 5 ~DGIU 1 mIU[D])yRT. [3]
The fractions of the native protein, the intermediate, and the
unfolded protein at different urea concentrations were calcu-
lated from the urea dependence of the equilibrium constant of
each transition (KNI and KIU) according to Eqs. 4 and 5.
KNI 5 exp 2(DGNI 1 mNI[D])yRT. [4]
KIU 5 exp 2(DGIU 1 mIU[D])yRT. [5]
RESULTS
Urea-Induced Unfolding Transitions of PrP(121–231). We
investigated the pH dependence of the urea-induced unfold-
ingyrefolding transition of murine PrP(121–231) at 22°C and a
constant ionic strength of 88 mM. The transitions were mon-
itored by the far-UV CD signal of PrP(121–231) at 222 nm. Fig.
1A shows the urea-induced unfolding and refolding of
PrP(121–231) between pH 4.0 and 7.0. All transitions were
completely reversible, and no protein aggregation was ob-
served under the conditions used. The transitions at pH 6.0 and
7.0 are apparent two-state transitions with similar cooperat-
ivities, transition midpoints, and free energies of folding of
228 and 231 kJ mol21, respectively (Table 1). In contrast, the
unfolding transitions at pH 4.0 and 4.5 are shifted to lower urea
concentrations and are characterized by the presence of an
equilibrium unfolding intermediate seen as a plateau in the
transition profiles (Fig. 1 A). Three-state analysis of the data
revealed that the unfolding intermediate is maximally popu-
lated to 95% at pH 4.0 and 3.5 M urea (Fig. 1B) and to about
85% at pH 4.5 and 4.5 M urea. A mixed situation is observed
at pH 5.0, where PrP(121–231) is significantly less stable
compared with pH 6.0 and 7.0, but the plateau is only
marginally developed (Fig. 1A). Table 1 shows the relative
stabilities of the intermediate, native, and unfolded PrP(121–
231) in the absence of denaturant. The intermediate is closer
in its free energy to native PrP(121–231) at pH 4.0 and closer
to unfolded PrP(121–231) at pH 4.5 (Table 1), indicating that
the intermediate is absent at higher pH values. The higher
stability of the intermediate at pH 4.0 is reflected by its
fraction in the absence of denaturant, which is 0.2% at pH 4.0
and 0.0002% at pH 4.5.
Acid-Induced Unfolding of PrP(121–231) at Constant De-
naturant Concentration. The pH dependence of the formation
of the intermediate was followed at a constant urea concen-
tration of 3.5 M where all molecules are native at pH 7.0 and
the intermediate is maximally populated at pH 4.0 (see. Fig.
1A). Two pH-dependent processes were observed (Fig. 2). The
first transition with an apparent pKa of 4.5 corresponds to the
transition from native PrP(121–231) to the unfolding interme-
diate. The second process with an apparent pKa of 3.3 was
assigned to the transition from the intermediate to an unfolded
state at acidic pH. The apparent pKa of 4.5 of the first
transition suggests that acidic residues in PrP(121–231) are
titrated upon formation of the intermediate. The transitions
are significantly steeper than expected from two single acidy
base equilibria, demonstrating that several acidic side chains
are protonated in each of the transitions (25). The interme-
diate is not measurably populated in 3.5 M urea above pH 5.5
but is still present during urea-induced unfolding of PrP(121–
231) at pH 5.0.
Spectroscopic Characterization of the Intermediate. To
compare the structural features of the intermediate with native
and unfolded PrP(121–231), the far-UV CD spectra of all
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three states were recorded at pH 4.0 (Fig. 3). The shape of the
spectrum of native PrP(121–231) is identical with the spectrum
at pH 7.0 with minima at 208 and 222 nm (mean residue
ellipticity at 222 nm, 213,600 degreeszcm2ydegreesz
cm2zdmol21) that are diagnostic for the high a-helix content in
PrP(121–231). In contrast, the spectrum of the intermediate
has a minimum at 215 nm with a mean residue ellipticity of
27,000 degzcm2ydmol that indicates a high content of b-sheet
secondary structure and a strong decline of a-helix content in
the intermediate (26).
Kinetics of the Formation of the Intermediate. The kinetics
of formation of the equilibrium unfolding intermediate were
analyzed at pH 4.0. The native protein and the unfolded
protein (in 8 M urea) were diluted with buffer to a final urea
concentration of 3.5 M where the intermediate is maximally
populated. In both cases, the CD signal of the intermediate was
formed within the dead time of manual mixing (about 15 s;
data not shown), demonstrating that the equilibria between the
native or unfolded state and the intermediate of PrP(121–231)
are very rapid.
DISCUSSION
In this study we have demonstrated that the C-terminal domain
of the prion protein (i.e., the only segment in PrPC with defined
tertiary structure) can adopt an alternative conformation at
acidic pH with spectral characterisitics of a b-sheet protein.
Therefore, structural differences between PrPC and PrPSc
subunits may not be restricted to the prion protein segment
90–120, and the C-terminal domain PrP(121–231) may also
undergo a conformational change during the conversion of
PrPC into PrPSc. This is strongly supported by the fact that the
epitope recognized by the only PrPSc-specific antibody that is
presently available is composed of three segments from
PrP(121–231) (27). An acid-induced unfolding intermediate
with b-sheet properties has recently also been observed during
guanidinium chloride-induced unfolding transitions of the
recombinant fragment 90–231 from human PrP (21). We have
FIG. 1. (A) Reversible unfolding transitions of PrP(121–231) at
22°C in the presence of urea at pH 4.0 (), 4.5 (■ ), 5.0 (}), 6.0 (Œ),
and 7.0 (F). (A) Mean residue ellipticities at 222 nm. The solid lines
result from fitting the data according to a two-state model for pH 5.0,
pH 6.0, and pH 7.0 and according to a three-state model for pH 4.0
and pH 4.5. The corresponding refolding experiments are represented
by open symbols. (B) Three-state analysis of the fractions of the native
(‚), intermediate (F), and unfolded state (h) of PrP(121–231) at pH
4.0.
FIG. 2. Acid-induced unfolding of PrP(121–231) in the presence of
3.5 M urea monitored by the mean residue ellipticity at 222 nm.
Table 1. Thermodynamic parameters of urea-induced folding of PrP(121–231) between pH 4.0 and
pH 7.0 at 22°C
Parameter pH 7.0 pH 6.0 pH 4.5 pH 4.0
DGNU, kJ mol21 228.6 6 0.95 232.1 6 1.30
mNU, kJ mol21 M21 4.73 6 0.16 5.61 6 0.16
Urea1/2, M 6.05 5.72
DGNI, kJ mol21 231.1 6 1.3 215.5 6 1.2
mNI, kJ mol21 M21 8.53 6 0.41 7.12 6 0.48
Urea1/2, M 3.65 2.18
DGIU, kJ mol21 222.4 6 5.4 227.4 6 3.2
mIU, kJ mol21 M21 3.82 6 0.89 5.54 6 0.64
Urea1/2, M 5.86 4.94
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now shown that the formation of the acid-induced intermedi-
ate is an intrinsic property of the C-terminal domain PrP(121–
231) and independent of segment 90–120.
Monomeric folding intermediates of amyloidogenic proteins
have previously been proposed as precursors of amyloid for a
variety of amyloidogenic diseases (28, 29). We have demon-
strated that the equilibrium unfolding intermediate of
PrP(121–231) is in a rapid equilibrium with the native and
unfolded state. This is consistent with the nucleationy
condensation model for the formation of the infectious PrPSc
oligomer (12), which postulates a fast equilibrium between
monomers of PrPC and PrPSc and a rate-limiting association of
PrPSc monomers to an oligomer of critical size that forms a
nucleus for further irreversible incorporation of PrPSc mono-
mers into a growing PrPSc oligomer. Within the framework of
this model, any change in solvent conditions that shifts the
PrPCyPrPSc equilibrium toward PrPSc would accelerate the
formation of oligomeric PrPSc. A change in solvent conditions,
namely a shift from physiological to acidic pH, may indeed
occur during the conversion of PrPC into PrPSc in vivo: The cell
surface protein PrPC is normally exposed to physiological pH.
PrPC appears to be clustered in cholesterol-rich invaginations
of the plasma membrane termed caveolae (30), which may bud
from the membrane and fuse with endosomes in a clathrin-
independent endocytosis pathway. Intriguingly, insoluble
PrPSc amyloid accumulates in the endosomal lumen of scrapie-
infected cells (31, 32) where the pH varies between 4.0 and 6.0
(33), indicating that the propagation of the infectious scrapie
agent may occur during endocytosis at acidic pH. This agrees
with our experimental data that show that the unfolding
intermediate of PrP(121–231) with b-sheet characteristics is
only populated below pH 5.0 (Fig. 2). A quantitative analysis
demonstrates that the intermediate is also significantly present
in the absence of urea at pH 4.0. The following scheme
presents a deduced model for the propagation of PrPSc in
endosomes, where the unfolding intermediate (I) should be
populated at equilibrium in addition to the native (N) and
unfolded (U) state and could be removed from the equilibrium
by irreversible incorporation into the PrPSc oligomer.
physiological pH: Nº U




In this context, it is important to note that equilibrium
unfolding intermediates are rather frequently observed during
protein folding studies at acidic pH and have been extensively
analyzed in the case of apomyoglobin (25) and staphylococcal
nuclease (34). However, these intermediates generally contain
native-like secondary structures, whereas the far-UV CD
spectrum of the unfolding intermediate of PrP(121–231) lacks
the native a-helical features. The apparent pKa of 4.5 mea-
sured for the transition from native PrP(121–231) to the
intermediate (Fig. 2) is reminiscent of the conformational
change in influenza hemagglutinin that is also induced by
mildly acidic conditions (pH 5.0) and required for fusion of the
viral membrane with the endosomal membrane of infected
animal cells (35). The conformational transition in hemagglu-
tinin is, however, irreversible and kinetically controlled (35).
For the domain PrP(121–231), the conformational change is
reversible but may be followed by irreversible oligomerization
of PrP. Importantly, acid pH has also been shown to promote
the formation of amyloid fibrils of another amyloidogenic
protein, transthyretin, which represents the main b-sheet
amyloid deposit of familial amyloidotic polyneuropathy (36,
37).
The model of an acid-induced unfolding intermediate of
PrPC that acts as possible monomeric precursor of the scrapie
agent is also supported by the known amino acid exchanges in
human PrP that have been associated with inherited human
prion diseases (2): Like the protonation of acidic residues at
low pH, the disease-related point mutations in human PrP that
involve acidic residues (Asp178Asn and Glu200Lys) remove
negative charges. Asp-178 and Glu-200 are located at the N
terminus of the second and third helix of PrP(121–231),
respectively (15). The mutations may thus eliminate favorable
interactions of these residues with the helix dipoles and
facilitate the formation of the intermediate. The fact that the
intermediate can be almost quantitatively populated at equi-
librium opens the possibility to determine its structure in
solution by NMR spectroscopy. Acidic pH and endocytosis
may also represent important experimental parameters for
successful propagation of the infectious scrapie agent in vitro.
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sische Technische Hochschule Zürich, the Schweizerische National-
fonds [Project 4381.050285 (R.G.)], and the Boehringer-Ingelheim-
Fonds (grant to S.H.).
1. Weissmann, C., Fischer, M., Raeber, A., Büeler, H., Sailer, A.,
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